2013 American Transplant Congress
Enhanced Liver Regeneration in Mice Lacking the Chemokine Receptor CCR5
Introduction: Further knowledge of basic mechanisms that regulate liver regeneration may help to find therapies to increase otherwise insufficient liver mass. The chemokine receptor CCR5…2013 American Transplant Congress
Influence of Organ Retrieval Team on Mid-Term Outcome of Lung Transplantation
Purpose Due to a zonal organ allocation scheme introduced in United Kingdom, organ retrieval is performed frequently by different centers. This study evaluates the influence…2013 American Transplant Congress
Effect of Induction Therapy with Thymoglobulin on Outcome in Hepatitis C Infected Kidney Transplant Recipients: A Single Center Experience
Virginia Commonwealth University, Richmond
This study evaluated the impact of induction therapy with thymoglobulin (ATG) on outcome in hepatitis C virus positive (HCV+) kidney transplant recipients.We retrospectively studied 79…2013 American Transplant Congress
Utility of Serum Markers in Evaluating Graft Pancreatitis Following Simultaneous Pancreas-Kidney Transplantation
INTRODUCTION. Graft pancreatitis remains difficult to diagnose using clinical assessment alone, leading to indiscriminate use of cross-sectional imaging. We seek to correlate the presence of…2013 American Transplant Congress
PI3Kδ Inhibition Augments the Efficacy of mTOR Inhibitor Rapamycin on the Proliferation of Epstein-Barr Virus (EBV)+ B Cell Lymphomas
Department of Surgery, Stanford University School of Medicine, Stanford, CA
Post-transplant lymphoproliferative disorder (PTLD) is a devastating and potentially life-threatening complication in transplant recipients. PTLD is associated with EBV infection and can result in malignant…2013 American Transplant Congress
Identification of EBV-Specific CXCR3+/CXCR5+ CD8+T Cells in Peripheral Blood of Asymptomatic Pediatric Heart Transplant Recipients Who Carry EBV Loads
Unlike immunocompetent healthy subjects who carry EBV infection in a latent form, approximately 70% of EBV asymptomatic immunosuppressed pediatric heart transplant (HTx) recipients carry chronic…2013 American Transplant Congress
Safety Risks in Living Donor Liver Transplantation
OBJECTIVE/BACKGROUND:According to the 2010 U.S. Office of the Inspector General’s Report, adverse events (AE) are common in the care of patients. In Living Donor Liver…2013 American Transplant Congress
Three Genotypically Distinct Strains of Pneumocystis Jirovecii Caused an Outbreak of Pneumocystis Pneumonia in Renal and Liver Transplant Recipients
Background: Pneumocystis jirovecii pneumonia (PCP) is a serious and possibly lethal opportunistic infection in immunocompromised patients. An outbreak of 29 PCP cases occurred among renal…2013 American Transplant Congress
Time on Waiting List for Patients with High MELD Does Not Influence Graft or Patient Survival after Liver Transplantation
Northwestern University, Chicago
BACKGROUND: With the decreased donor availability, even patients with high MELD scores can have prolonged wait times for liver transplantation (LT). However, it is unknown…2013 American Transplant Congress
Injected Allogeneic CD4+CD25+ Tregs Regulate the Neonatal Immune System and Prolong Heart Allograft Survival
University of Alberta, Edmonton, Canada
Introduction/Methods: Semi-allogeneic (F1; H-2k/b) splenocytes (SC) injected into newborn mice (H-2k) induce immunological tolerance whereas allogeneic SC (H-2b) lead to graft-vs-host disease (GVHD). Here we…
- « Previous Page
- 1
- …
- 100
- 101
- 102
- 103
- 104
- …
- 178
- Next Page »